BLOOMINGTON, Ind.--(BUSINESS WIRE)--The "Impact of Sex and Vascular Diseases and Implications for Therapies" symposium uncovered a series of knowledge gaps related to the sex differences in vascular disease, its symptoms, risk factors and response to treatment. Conference recommendations could make a significant impact on the health care industry ranging from clinical trials to the development of medical technology and therapies. Preliminary findings reveal that the basic biological make up of the heart and blood vessels differs significantly between men and women and may have a direct and dramatic impact on the prevention, diagnosis and treatment of heart attacks, strokes and other forms of vascular disease. Symposium faculty also report that reproductive hormones such as estrogen heavily influence the progression and treatment of vascular disease.
